1. Loss of DUSP4 Expression as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
   Seongsik Bang et al, 2021, Diagnostics CrossRef
2. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis
   Jiying Shen et al, 2024, BMC Cancer CrossRef
3. Inhibition of microRNA-122 alleviates pyroptosis by targeting dual-specificity phosphatase 4 in myocardial ischemia/reperfusion injury
   Hongjin Wu et al, 2023, Heliyon CrossRef
4. The Importance of miRNA in the Diagnosis and Prognosis of Papillary Thyroid Cancer
   Mariusz Rogucki et al, 2021, Journal of Clinical Medicine CrossRef
5. Repression of linc01555 up-regulates angiomotin-p130 via the microRNA-122-5p/clic1 axis to impact vasculogenic mimicry-mediated chemotherapy resistance in small cell lung cancer
   Dan Li et al, 2023, Cell Cycle CrossRef
6. Cancer stem cell-like cells-derived exosomal lncRNA CDKN2B-AS1 promotes biological characteristics in thyroid cancer via miR-122-5p/P4HA1 axis
   Qinghua Wu et al, 2023, Regenerative Therapy CrossRef
7. Circ_LRP6 facilitates osteosarcoma progression via the miR‐122‐5p/miR‐204‐5p/HMGB1 axis
   Guanghui Wang et al, 2023, Environmental Toxicology CrossRef
8. Dual-Specificity Phosphatases and Kidney Diseases
   Haiyang Li et al, 2022, Kidney Diseases CrossRef
9. Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction
   Giulia Dal Santo et al, 2022, Computational and Structural Biotechnology Journal CrossRef
10. Expression of SOX2OT, DANCR and TINCR long non‑coding RNAs in papillary thyroid cancer and its effects on clinicopathological features
    Fadime Icduygu et al, 2022, Molecular Medicine Reports CrossRef
11. MicroRNA-122 in human cancers: from mechanistic to clinical perspectives
    Mahboobeh Faramin Lashkarian et al, 2023, Cancer Cell International CrossRef